{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T06:22:17Z","timestamp":1766211737849,"version":"3.48.0"},"reference-count":27,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2025.j115","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:08:46Z","timestamp":1759356526000},"page":"383-392","source":"Crossref","is-referenced-by-count":0,"title":["Expressions of VEGF, Vasohibin-1, and Vasohibin-2 in Benign Parotid Gland Tumor"],"prefix":"10.1620","volume":"267","author":[{"given":"Yutaka","family":"Tateda","sequence":"first","affiliation":[{"name":"Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Ise","sequence":"additional","affiliation":[{"name":"Technical Services Division, Tohoku Medical and Pharmaceutical University"},{"name":"Division of Pathology, Tohoku Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shimada","sequence":"additional","affiliation":[{"name":"Division of Pathology, Tohoku Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Pathology, Tohoku Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Ohta","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology, Tohoku Medical and Pharmaceutical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Bia\u0142ek, E.J., Jakubowski, W.&amp;Karpinska, G. (2003)  Role of ultrasonography in diagnosis and differentiation of pleomorphic adenomas: work in progress. <i>Arch. Otolaryngol. Head Neck Surg<\/i>., 129, 929-933.","DOI":"10.1001\/archotol.129.9.929"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Ellis, L.M.&amp;Hicklin, D.J. (2008)  VEGF-targeted therapy: mechanisms of anti-tumour activity. <i>Nat. Rev. Cancer<\/i>, 8, 579-591.","DOI":"10.1038\/nrc2403"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Faur, A.C., Lazar, E.&amp;Cornianu, M. (2014)  Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours. <i>APMIS<\/i>, 122, 418-426.","DOI":"10.1111\/apm.12160"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Folkman, J. (1971)  Tumor angiogenesis: therapeutic implications. <i>N. Engl. J. Med<\/i>., 285, 1182-1186.","DOI":"10.1056\/NEJM197111182852108"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Hara, H., Ozawa, S., Ninomiya, Y., Yamamoto, M., Ogimi, M., Nabeshima, K., Nakamura, K., Kajiwara, H., Nakamura, N.&amp;Sato, Y. (2020)  Prognostic significance of vasohibin-1 and vasohibin-2 immunohistochemical expression in gastric cancer. <i>Surg. Today<\/i>, 50, 1530-1543.","DOI":"10.1007\/s00595-020-02040-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hosaka, T., Kimura, H., Heishi, T., Suzuki, Y., Miyashita, H., Ohta, H., Sonoda, H., Moriya, T., Suzuki, S., Kondo, T.&amp;Sato, Y. (2009)  Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. <i>Am. J. Pathol<\/i>., 175, 430-439.","DOI":"10.2353\/ajpath.2009.080788"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Iida-Norita, R., Kawamura, M., Suzuki, Y., Hamada, S., Masamune, A., Furukawa, T.&amp;Sato, Y. (2019)  Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma. <i>Cancer Sci<\/i>., 110, 2296-2308.","DOI":"10.1111\/cas.14041"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Isoda, R., Morita, I., Ishida, A., Mikami, Y., Monobe, Y., Sato, Y.&amp;Moriya, T. (2022)  Pathological Study on the Expression of Vasohibins in Peripheral Artery Disease. <i>Tohoku J. Exp. Med<\/i>., 258, 121-128.","DOI":"10.1620\/tjem.2022.J063"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Kimura, H., Miyashita, H., Suzuki, Y., Kobayashi, M., Watanabe, K., Sonoda, H., Ohta, H., Fujiwara, T., Shimosegawa, T.&amp;Sato, Y. (2009)  Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. <i>Blood<\/i>, 113, 4810-4818.","DOI":"10.1182\/blood-2008-07-170316"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kobayashi, H., Kosaka, T., Mikami, S., Miyazaki, Y., Matsumoto, K., Kikuchi, E., Miyajima, A., Kameyama, K., Sato, Y.&amp;Oya, M. (2017)  Vasohibin-1 as a novel microenvironmental biomarker for patient risk reclassification in low-risk prostate cancer. <i>Oncotarget<\/i>, 9, 10203-10210.","DOI":"10.18632\/oncotarget.23011"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kobayashi, M., Wakabayashi, I., Suzuki, Y., Fujiwara, K., Nakayama, M., Watabe, T.&amp;Sato, Y. (2021)  Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors. <i>Angiogenesis<\/i>, 24, 159-176.","DOI":"10.1007\/s10456-020-09754-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Mikami, S., Oya, M., Kosaka, T., Mizuno, R., Miyazaki, Y., Sato, Y.&amp;Okada, Y. (2017)  Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients. <i>Lab. Invest<\/i>., 97, 854-862.","DOI":"10.1038\/labinvest.2017.26"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Miyazaki, Y., Kosaka, T., Mikami, S., Kikuchi, E., Tanaka, N., Maeda, T., Ishida, M., Miyajima, A., Nakagawa, K., Okada, Y., Sato, Y.&amp;Oya, M. (2012)  The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma. <i>Clin. Cancer Res<\/i>., 18, 4145-4153.","DOI":"10.1158\/1078-0432.CCR-12-0073"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ninomiya, Y., Ozawa, S., Oguma, J., Kazuno, A., Nitta, M., Kajiwara, H.&amp;Sato, Y. (2018)  Expression of vasohibin-1 and -2 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus. <i>Oncol. Lett<\/i>., 16, 5265-5274.","DOI":"10.3892\/ol.2018.9249"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Sato, Y. (2003)  Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy. <i>Int. J. Clin. Oncol<\/i>., 8, 200-206.","DOI":"10.1007\/s10147-003-0342-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Sato, Y. (2013)  The vasohibin family: a novel family for angiogenesis regulation. <i>J. Biochem<\/i>., 153, 5-11.","DOI":"10.1093\/jb\/mvs128"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Sato, Y.&amp;Sonoda, H. (2007)  The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. <i>Arterioscler. Thromb. Vasc. Biol<\/i>., 27, 37-41.","DOI":"10.1161\/01.ATV.0000252062.48280.61"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Shibuya, T., Watanabe, K., Yamashita, H., Shimizu, K., Miyashita, H., Abe, M., Moriya, T., Ohta, H., Sonoda, H., Shimosegawa, T., Tabayashi, K.&amp;Sato, Y. (2006)  Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. <i>Arterioscler. Thromb. Vasc. Biol<\/i>., 26, 1051-1057.","DOI":"10.1161\/01.ATV.0000216747.66660.26"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Suzuki, Y., Kobayashi, M., Miyashita, H., Ohta, H., Sonoda, H.&amp;Sato, Y. (2010)  Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion. <i>J. Cell Sci<\/i>., 123, 3094-3101.","DOI":"10.1242\/jcs.067538"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Takahashi, Y., Koyanagi, T., Suzuki, Y., Saga, Y., Kanomata, N., Moriya, T., Suzuki, M.&amp;Sato, Y. (2012)  Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. <i>Mol. Cancer Res<\/i>., 10, 1135-1146.","DOI":"10.1158\/1541-7786.MCR-12-0098-T"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Tamaki, K., Moriya, T., Sato, Y., Ishida, T., Maruo, Y., Yoshinaga, K., Ohuchi, N.&amp;Sasano, H. (2009)  Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. <i>Cancer Sci<\/i>., 100, 88-94.","DOI":"10.1111\/j.1349-7006.2008.01015.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Tateda, Y., Suzuki, T., Sato, T., Izuhara, K., Ise, K., Shimada, H., Murakami, K., Murakami, K., Nakamura, Y.&amp;Ohta, N. (2024)  Expression of Periostin in Benign Salivary Gland Tumors. <i>Tohoku J. Exp. Med<\/i>., 262, 105-113.","DOI":"10.1620\/tjem.2023.J099"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Teymoortash, A., Schrader, C., Shimoda, H., Kato, S.&amp;Werner, J.A. (2007)  Evidence of lymphangiogenesis in Warthin\u2019s tumor of the parotid gland. <i>Oral Oncol<\/i>., 43, 614-618.","DOI":"10.1016\/j.oraloncology.2006.07.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Watanabe, K., Hasegawa, Y., Yamashita, H., Shimizu, K., Ding, Y., Abe, M., Ohta, H., Imagawa, K., Hojo, K., Maki, H., Sonoda, H.&amp;Sato, Y. (2004)  Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. <i>J. Clin. Invest<\/i>., 114, 898-907.","DOI":"10.1172\/JCI200421152"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Xue, X., Gao, W., Sun, B., Xu, Y., Han, B., Wang, F., Zhang, Y., Sun, J., Wei, J., Lu, Z., Zhu, Y., Sato, Y., Sekido, Y., Miao, Y.&amp;Kondo, Y. (2013)  Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. <i>Oncogene<\/i>, 32, 1724-1734.","DOI":"10.1038\/onc.2012.177"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Yoshinaga, K., Ito, K., Moriya, T., Nagase, S., Takano, T., Niikura, H., Sasano, H., Yaegashi, N.&amp;Sato, Y. (2011)  Roles of intrinsic angiogenesis inhibitor, vasohibin, in cervical carcinomas. <i>Cancer Sci<\/i>., 102, 446-451.","DOI":"10.1111\/j.1349-7006.2010.01812.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Yoshinaga, K., Ito, K., Moriya, T., Nagase, S., Takano, T., Niikura, H., Yaegashi, N.&amp;Sato, Y. (2008)  Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. <i>Cancer Sci<\/i>., 99, 914-919.","DOI":"10.1111\/j.1349-7006.2008.00777.x"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/267\/4\/267_2025.J115\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T04:06:35Z","timestamp":1766203595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/267\/4\/267_2025.J115\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j115","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"type":"print","value":"0040-8727"},{"type":"electronic","value":"1349-3329"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025.J115"}}